NPI: 1235192113 · CHARLOTTE, NC 28211 · 207W00000X
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 17,329 | $699K |
| 2019 | 18,501 | $723K |
| 2020 | 15,421 | $637K |
| 2021 | 21,858 | $771K |
| 2022 | 19,626 | $761K |
| 2023 | 17,860 | $705K |
| 2024 | 16,613 | $645K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| S0621 | Routine ophthalmological exa | 11,027 | 9,926 | $874K |
| 92014 | 13,543 | 11,799 | $862K | |
| 92004 | 8,315 | 7,309 | $786K | |
| S0620 | Routine ophthalmological exa | 4,639 | 4,214 | $440K |
| 92060 | 10,750 | 9,415 | $412K | |
| 92340 | 23,659 | 20,714 | $404K | |
| 92015 | 9,307 | 7,457 | $177K | |
| 99213 | 3,722 | 3,038 | $175K | |
| 99214 | 3,282 | 2,740 | $168K | |
| 92370 | 23,581 | 21,131 | $149K | |
| 92012 | 2,841 | 2,429 | $147K | |
| 67028 | 1,714 | 1,144 | $101K | |
| 99204 | 612 | 560 | $68K | |
| 99232 | 1,134 | 514 | $59K | |
| 92134 | 4,088 | 3,311 | $49K | |
| 99254 | 400 | 315 | $47K | |
| 99223 | Prolong inpt eval add15 m | 74 | 71 | $11K |
| 92201 | 2,673 | 1,196 | $3K | |
| 92083 | 131 | 107 | $3K | |
| J9035 | Bevacizumab injection | 46 | 37 | $2K |
| 99233 | Prolong inpt eval add15 m | 24 | 12 | $2K |
| 92133 | 72 | 64 | $2K | |
| 99203 | 15 | 15 | $1K | |
| 92226 | 511 | 266 | $188.28 | |
| 92225 | 93 | 88 | $88.83 | |
| V2020 | Vision svcs frames purchases | 285 | 163 | $19.49 |
| V2103 | Spherocylindr 4.00d/12-2.00d | 456 | 122 | $0.00 |
| V2104 | Spherocylindr 4.00d/2.12-4d | 214 | 69 | $0.00 |